Kezar Life Sciences, Inc. Common Stock
Symbol: KZR (NASDAQ)
3.93
▲ (0.90%) 0.035
Company Description:
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Key Stats
- Today's Open: $3.85
- Today's High: $4.035
- Today's Low: $3.78
- Today's Volume: 53.83K
- Yesterday Close: $3.89
- Yesterday High: $4.0975
- Yesterday Low: $3.845
- Yesterday Volume: 35.58K
- Last Min Volume: 10
- Last Min High: $3.925
- Last Min Low: $3.925
- Last Min VWAP: $3.925
Company Profile
- Name: Kezar Life Sciences, Inc. Common Stock
- Website: https://www.kezarlifesciences.com
- Listed Date: 2018-06-21
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001645666
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $28.71M
- Round Lot: 100
- Outstanding Shares: 7.32M
- Asset Type: CS
RECENT FILINGS FOR KZR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-25 | ARS | View |
| 2025-04-25 | DEFA14A | View |
| 2025-04-25 | DEF 14A | View |
| 2025-04-16 | 3 | View |
Latest News on KZR